Latest Product Innovation News

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.

Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.

Pinnacle Investment Management delivered a 31.5% jump in net profit after tax to $176.7 million for FY26, boosted by full ownership of Pacific Asset Management and strong inflows across retail, institutional, and international channels.

Unith Ltd has issued over 222 million securities, raising $1 million via share placement and converting $500,000 of debt to equity, while attaching options await shareholder approval.

OMG Group smashed its July sales record with net sales soaring to approximately $738,000, a 120% jump on last year, reversing typical seasonal declines and boosted by a refreshed Blue Dinosaur brand.

Orbital Corporation broadened its international footprint with new UAV propulsion orders across the US, India, and Middle East, while advancing its Power by the Hour service to underpin recurring revenue streams.

Pointerra Limited boosted its FY26 performance with a 33% rise in Q4 customer receipts and multi-year contracts from top utilities, underpinning improved cashflow and platform expansion.

Betr Entertainment reported its first positive operating cash flow since 2021 with $2.6 million in Q4 FY26, driven by improved customer engagement and promotional efficiency. The company enters FY27 with strong momentum, including over 15% turnover growth in July excluding World Cup effects and record Same Game Multi volumes.

Raiz Invest reported robust Q4 FY26 growth with active customers climbing 6.7% and funds under management hitting $2.32 billion, while confirming FY26 profitability guidance.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.

The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.